As these medications evolved, Watanabe said, "there was this more profound weight loss that was observed that really sort of came to culmination with this drug called semaglutide." Enter the GLP-1 popularity boom
Make sure to stay hydrated and have a healthy balanced diet as you go along in taking Ozempic
51.4% of Patients Would Consider Using GLP-1 Drugs Again 51.4% of participants said they would use GLP-1s again
(PubMed) Wang H, Li L, Qin LL, Song Y, Vidal-Alaball J, Liu TH
Among the most promising candidates, supported by phase 1 and 2 clinical trials, is cagrilintide, a long-acting amylin and calcitonin receptor agonist
This is the maintenance phase: the dose stays the same while the body continues to respond to the medications appetite-regulating and metabolic effects